Companies leading charge to develop coronavirus vaccine to appear before Congress

Jul 9, 2020
Press Release
AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer to testify before key House oversight panel July 21

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House Energy and Commerce Oversight and Investigations Subcommittee, announced today that the panel will hold a hearing Tuesday, July 21, to hear directly from the five U.S. companies that are currently leading the race to develop a coronavirus vaccine. 

The hearing comes as some public health officials have raised concerns about the rapid pace that some of these vaccines are being developed and whether long-standing safety and effectiveness standards are still being followed. 

Officials from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer are all set to testify at the hearing.

“This hearing will provide an opportunity for both Congress and the American people to hear directly from some of the manufacturers currently developing potential COVID-19 vaccines,” DeGette and the full committee’s chairman Rep. Frank Pallone Jr. (D-NJ) said in a joint statement. “We look forward to hearing from each of the companies about their research and development efforts, safety and efficacy standards and their ongoing preparations to manufacture and distribute an eventual vaccine.”

The Energy and Commerce Oversight and Investigations panel – led by DeGette – directly oversees the nation’s top health agencies including: the Centers for Diseases Control and Prevention, Department of Health and Human Services, Food and Drug Administration and the National Institutes of Health. 

Additional details regarding the hearing – including how to view it remotely – will be announced next week.